DD GROUP Co.,Ltd. Logo

DD GROUP Co.,Ltd.

Operates a diverse portfolio of food service, amusement, and hotel brands.

3073 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区芝4−1−23 三田NNビル18F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DD GROUP Co., Ltd. is a multifaceted enterprise principally engaged in the food service and amusement sectors. The company's core activities involve the planning, management, and operation of a diverse portfolio of businesses, including themed restaurants, pubs, cafes, and amusement facilities. The group has also expanded its operations to include the hotel business. Emphasizing a "brand company" philosophy, DD GROUP is dedicated to the continuous creation and development of innovative brands. Through its various group companies, it manages over 100 distinct brands across an extensive network of locations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 09:00
M&A Activity
訂正意見表明報告書
Japanese 229.2 KB
2025-07-15 07:18
M&A Activity
意見表明報告書
Japanese 425.5 KB
2025-05-30 09:01
Governance Information
内部統制報告書-第29期(2024/03/01-2025/02/28)
Japanese 24.4 KB
2025-05-30 09:00
Registration Form
有価証券報告書-第29期(2024/03/01-2025/02/28)
Japanese 1.8 MB
2025-05-30 09:00
Registration Form
確認書
Japanese 9.0 KB
2025-05-30 04:00
Regulatory News Service
臨時報告書
Japanese 24.8 KB
2025-04-14 09:15
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-02-28 03:00
Post-Annual General Meeting Information
臨時報告書
Japanese 22.3 KB
2024-10-15 09:00
Interim Report
半期報告書-第29期(2024/03/01-2025/02/28)
Japanese 279.9 KB
2024-10-15 09:00
Interim Report
確認書
Japanese 9.0 KB
2024-07-12 09:00
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-07-12 09:00
Quarterly Report
四半期報告書-第29期第1四半期(2024/03/01-2024/05/31)
Japanese 223.4 KB
2024-07-02 09:12
Major Shareholding Notification
変更報告書
Japanese 40.0 KB
2024-05-30 09:01
Governance Information
内部統制報告書-第28期(2023/03/01-2024/05/29)
Japanese 23.8 KB
2024-05-30 09:00
Registration Form
有価証券報告書-第28期(2023/03/01-2024/02/29)
Japanese 1.8 MB

Automate Your Workflow. Get a real-time feed of all DD GROUP Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DD GROUP Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.